• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感病毒 NS1 的分子动力学模拟揭示了一个具有显著稳定性的 RNA 结合结构域,其中包含有很有前途的可药物结合口袋。

Molecular Dynamics Simulations of Influenza A Virus NS1 Reveal a Remarkably Stable RNA-Binding Domain Harboring Promising Druggable Pockets.

机构信息

Université de Paris, BFA, UMR 8521, CNRS, ERL U1133, Inserm, F-75013 Paris, France.

Equipe 3IMo, UMR1282 Infectiologie et Santé Publique, INRAE, F-37380 Nouzilly, France.

出版信息

Viruses. 2020 May 14;12(5):537. doi: 10.3390/v12050537.

DOI:10.3390/v12050537
PMID:32422922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290946/
Abstract

The non-structural protein NS1 of influenza A viruses is considered to be the major antagonist of the interferon system and antiviral defenses of the cell. It could therefore represent a suitable target for novel antiviral strategies. As a first step towards the identification of small compounds targeting NS1, we here investigated the druggable potential of its RNA-binding domain since this domain is essential to the biological activities of NS1. We explored the flexibility of the full-length protein by running molecular dynamics simulations on one of its published crystal structures. While the RNA-binding domain structure was remarkably stable along the simulations, we identified a flexible site at the two extremities of the "groove" that is delimited by the antiparallel α-helices that make up its RNA-binding interface. This groove region is able to form potential binding pockets, which, in 60% of the conformations, meet the druggability criteria. We characterized these pockets and identified the residues that contribute to their druggability. All the residues involved in the druggable pockets are essential at the same time to the stability of the RNA-binding domain and to the biological activities of NS1. They are also strictly conserved across the large sequence diversity of NS1, emphasizing the robustness of this search towards the identification of broadly active NS1-targeting compounds.

摘要

甲型流感病毒的非结构蛋白 NS1 被认为是干扰素系统和细胞抗病毒防御的主要拮抗剂。因此,它可能是新型抗病毒策略的合适靶点。作为鉴定靶向 NS1 的小分子的第一步,我们在此研究了其 RNA 结合域的可成药性潜力,因为该结构域对 NS1 的生物学活性至关重要。我们通过对其已发表晶体结构之一进行分子动力学模拟来探索全长蛋白的柔韧性。虽然 RNA 结合域结构在模拟过程中非常稳定,但我们在由构成其 RNA 结合界面的反平行α-螺旋限定的“沟槽”的两个末端处鉴定了一个柔性位点。该沟槽区域能够形成潜在的结合口袋,其中 60%的构象符合成药性标准。我们对这些口袋进行了表征,并确定了对其成药性有贡献的残基。所有参与成药性口袋的残基同时对 RNA 结合域的稳定性和 NS1 的生物学活性至关重要。它们在 NS1 的大序列多样性中也是严格保守的,这强调了这种搜索方法在鉴定广泛有效的 NS1 靶向化合物方面的稳健性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/824b4cd9a094/viruses-12-00537-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/497c9e2563e5/viruses-12-00537-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/68fc8286ad31/viruses-12-00537-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/824b4cd9a094/viruses-12-00537-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/497c9e2563e5/viruses-12-00537-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/68fc8286ad31/viruses-12-00537-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffae/7290946/824b4cd9a094/viruses-12-00537-g003.jpg

相似文献

1
Molecular Dynamics Simulations of Influenza A Virus NS1 Reveal a Remarkably Stable RNA-Binding Domain Harboring Promising Druggable Pockets.流感病毒 NS1 的分子动力学模拟揭示了一个具有显著稳定性的 RNA 结合结构域,其中包含有很有前途的可药物结合口袋。
Viruses. 2020 May 14;12(5):537. doi: 10.3390/v12050537.
2
Druggable Pockets at the RNA Interface Region of Influenza A Virus NS1 Protein Are Conserved across Sequence Variants from Distinct Subtypes.流感 A 病毒 NS1 蛋白 RNA 接口区域的可成药性口袋在不同亚型的序列变体中是保守的。
Biomolecules. 2022 Dec 29;13(1):64. doi: 10.3390/biom13010064.
3
Unveiling New Druggable Pockets in Influenza Non-Structural Protein 1: NS1-Host Interactions as Antiviral Targets for Flu.揭示流感非结构蛋白 1 中可成药的新结合口袋:作为流感抗病毒靶点的 NS1-宿主相互作用。
Int J Mol Sci. 2023 Feb 3;24(3):2977. doi: 10.3390/ijms24032977.
4
Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses.保守的表面特征构成了甲型和乙型流感病毒非结构蛋白1(NS1)的双链RNA结合位点。
J Biol Chem. 2007 Jul 13;282(28):20584-92. doi: 10.1074/jbc.M611619200. Epub 2007 May 1.
5
To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.打还是不打:大规模序列分析和结构特征描述揭示了新型抗流感病毒 NS1 药物靶点的潜力。
Virology. 2019 Sep;535:297-307. doi: 10.1016/j.virol.2019.04.009. Epub 2019 Apr 27.
6
A Second RNA-Binding Site in the NS1 Protein of Influenza B Virus.乙型流感病毒NS1蛋白中的第二个RNA结合位点。
Structure. 2016 Sep 6;24(9):1562-72. doi: 10.1016/j.str.2016.07.001. Epub 2016 Aug 18.
7
Influenza A Virus NS1 Protein Structural Flexibility Analysis According to Its Structural Polymorphism Using Computational Approaches.基于结构多态性的计算方法分析甲型流感病毒 NS1 蛋白结构的灵活性。
Int J Mol Sci. 2022 Feb 4;23(3):1805. doi: 10.3390/ijms23031805.
8
The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses.甲型和乙型流感病毒中,病毒NS1蛋白的RNA结合结构域和效应结构域在不同程度上保守。
Virology. 1996 Sep 1;223(1):41-50. doi: 10.1006/viro.1996.0453.
9
NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.NS1 蛋白作为一种新型抗流感靶标:作图-突变抗病毒策略揭示了新的潜在可成药热点,在病毒复制过程中发挥重要作用。
Virology. 2022 Jan 2;565:106-116. doi: 10.1016/j.virol.2021.11.001. Epub 2021 Nov 6.
10
The influenza A virus protein NS1 displays structural polymorphism.甲型流感病毒蛋白 NS1 表现出结构多态性。
J Virol. 2014 Apr;88(8):4113-22. doi: 10.1128/JVI.03692-13. Epub 2014 Jan 29.

引用本文的文献

1
Structural Investigations of Interactions between the Influenza a Virus NS1 and Host Cellular Proteins.流感病毒 NS1 与宿主细胞蛋白相互作用的结构研究。
Viruses. 2023 Oct 7;15(10):2063. doi: 10.3390/v15102063.
2
Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein.鉴定有前景的可成药结合位点及其靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域的灵活性。
Comput Struct Biotechnol J. 2023;21:2339-2351. doi: 10.1016/j.csbj.2023.03.029. Epub 2023 Mar 18.
3
Druggable Pockets at the RNA Interface Region of Influenza A Virus NS1 Protein Are Conserved across Sequence Variants from Distinct Subtypes.

本文引用的文献

1
The structure and conformational plasticity of the nonstructural protein 1 of the 1918 influenza A virus.1918 年甲型流感病毒非结构蛋白 1 的结构和构象可塑性。
Biochem Biophys Res Commun. 2019 Oct 8;518(1):178-182. doi: 10.1016/j.bbrc.2019.08.027. Epub 2019 Aug 14.
2
Influenza A Virus Protein NS1 Exhibits Strain-Independent Conformational Plasticity.甲型流感病毒蛋白 NS1 表现出株独立的构象可塑性。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.00917-19. Print 2019 Nov 1.
3
To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.
流感 A 病毒 NS1 蛋白 RNA 接口区域的可成药性口袋在不同亚型的序列变体中是保守的。
Biomolecules. 2022 Dec 29;13(1):64. doi: 10.3390/biom13010064.
4
Influenza A Virus NS1 Protein Structural Flexibility Analysis According to Its Structural Polymorphism Using Computational Approaches.基于结构多态性的计算方法分析甲型流感病毒 NS1 蛋白结构的灵活性。
Int J Mol Sci. 2022 Feb 4;23(3):1805. doi: 10.3390/ijms23031805.
5
Structure and Sequence Determinants Governing the Interactions of RNAs with Influenza A Virus Non-Structural Protein NS1.调控流感 A 病毒非结构蛋白 NS1 与 RNA 相互作用的结构和序列决定因素。
Viruses. 2020 Aug 27;12(9):947. doi: 10.3390/v12090947.
打还是不打:大规模序列分析和结构特征描述揭示了新型抗流感病毒 NS1 药物靶点的潜力。
Virology. 2019 Sep;535:297-307. doi: 10.1016/j.virol.2019.04.009. Epub 2019 Apr 27.
4
Baloxavir marboxil: the new influenza drug on the market.巴洛沙韦玛波西利:市场上的新型流感药物。
Curr Opin Virol. 2019 Apr;35:14-18. doi: 10.1016/j.coviro.2019.01.006. Epub 2019 Mar 8.
5
Identification, design and synthesis of novel pyrazolopyridine influenza virus nonstructural protein 1 antagonists.新型吡唑并吡啶流感病毒非结构蛋白 1 拮抗剂的鉴定、设计与合成。
Bioorg Med Chem Lett. 2019 May 1;29(9):1113-1119. doi: 10.1016/j.bmcl.2019.02.027. Epub 2019 Feb 26.
6
Influenza viruses - antiviral therapy and resistance.流感病毒——抗病毒治疗与耐药性
GMS Infect Dis. 2017 Apr 25;5:Doc04. doi: 10.3205/id000030. eCollection 2017.
7
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.巴洛沙韦玛波西利治疗成人和青少年单纯性流感。
N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197.
8
Major contribution of the RNA-binding domain of NS1 in the pathogenicity and replication potential of an avian H7N1 influenza virus in chickens.NS1 蛋白的 RNA 结合域对鸡源 H7N1 流感病毒致病性和复制能力的主要贡献。
Virol J. 2018 Mar 27;15(1):55. doi: 10.1186/s12985-018-0960-4.
9
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.全球季节性流感相关呼吸道死亡率的估计:一项建模研究。
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
10
A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.对同时对奥司他韦和扎那米韦敏感性降低的甲型和乙型临床流感感染的综述
Open Forum Infect Dis. 2017 May 18;4(3):ofx105. doi: 10.1093/ofid/ofx105. eCollection 2017 Summer.